Answers are grounded in this paper and cite their sources.
Demonstrates effective capecitabine removal using hemp waste-derived activated carbon, indicating a sustainable solution.
Capecitabine (CTN) is a widely used oral chemotherapeutic agent frequently detected in hospital effluents and aquatic environments, where it poses serious ecological and toxicological risks. In this study, a high surface area activated carbon derived from hemp waste-derived activated carbon waste was synthesized and evaluated for CTN removal from aqueous solutions. Under optimized conditions (adsorbent dose: 20 mg/50 mL; pH: 7.0; initial CTN concentration: 30 mg/L; contact time: 45 min; temperature: 293 K), a maximum removal efficiency of 99.12% was achieved. Kinetic analysis revealed that the adsorption process followed the pseudo second order model (R² = 0.999; RMSE and MAE minimized), indicating that surface interactions governed the adsorption rate. Equilibrium data were best described by the Langmuir isotherm model (R² = 0.9999), with a maximum adsorption capacity of 167.24 mg/g, confirming monolayer adsorption on a homogeneous surface. Thermodynamic parameters (ΔG° = −11.05 to −15.20 kJ/mol, ΔH° = +47.12 kJ/mol, ΔS° = +197.91 J/mol·K) demonstrated that the process is spontaneous, endothermic, and entropy driven, with improved adsorption at elevated temperatures. These results highlight hemp waste-derived activated carbon waste–derived activated carbon as a sustainable, low cost, and highly effective adsorbent for the removal of capecitabine from aqueous environments.
No takes yet. Share an insight, caveat, or question.
Bulduk et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: